Get all your news in one place.
100's of premium titles.
One app.
Start reading
Radio France Internationale
Radio France Internationale
RFI

French cancer vaccine shows promise against recurrent tumours

A laboratory at Transgene biotech company, which is working to develop a personalised cancer vaccine, in Illkirch-Graffenstaden, eastern France, on November 17, 2021. © AFP - PATRICK HERTZOG

A French biotech company presented encouraging data this week from early trials of a vaccine that aims to stop tumours recurring in cancer patients.

Transgene, a company based in the eastern French city of Strasbourg, says results from a phase I clinical trial of its cancer vaccine suggest it can produce an immune response that helps stop new tumours growing.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.